- Home
- BLFS
as 03-28-2025 4:00pm EST
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | BOTHELL |
| Market Cap: | 1.2B | IPO Year: | 1989 |
| Target Price: | $29.50 | AVG Volume (30 days): | 380.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.84 - $29.55 | Next Earning Date: | 03-03-2025 |
| Revenue: | $82,254,000 | Revenue Growth: | 8.44% |
| Revenue Growth (this year): | 20.68% | Revenue Growth (next year): | 21.74% |
Stock Insider Trading Activity of BioLife Solutions Inc. (BLFS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Mar 14 '25 | Sell | $25.20 | 8,327 | $209,135.52 | 43,165 | |
| DuRoss Amy | BLFS | Director | Mar 14 '25 | Sell | $24.96 | 5,632 | $140,574.72 | 23,811 | |
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Mar 11 '25 | Sell | $25.67 | 8,415 | $220,189.16 | 43,165 | |
| Berard Todd | BLFS | Chief Marketing Officer | Mar 11 '25 | Sell | $25.00 | 1,577 | $39,425.00 | 104,961 | |
| Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | Mar 11 '25 | Sell | $25.00 | 1,597 | $39,925.00 | 260,601 | |
| Wichterman Troy | BLFS | Chief Financial Officer | Mar 11 '25 | Sell | $25.00 | 4,151 | $103,775.00 | 116,809 | |
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Mar 3 '25 | Sell | $25.46 | 284 | $7,230.64 | 43,165 | |
| Berard Todd | BLFS | Chief Marketing Officer | Mar 3 '25 | Sell | $25.46 | 424 | $10,795.04 | 104,961 | |
| Foster Karen A. | BLFS | Chief Quality and Operations | Mar 3 '25 | Sell | $25.46 | 324 | $8,249.04 | 156,243 | |
| Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | Mar 3 '25 | Sell | $25.46 | 425 | $10,820.50 | 260,601 |
Latest BioLife Solutions Inc. News
BLFS Breaking Stock News: Dive into BLFS Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
BLFS: What does Argus have to say about BLFS?
Zacks
5 days ago
5 Low-Leverage Stocks to Buy Amid Trump's Tariff Woes
PR Newswire
11 days ago
BioLife Solutions Appoints Cathy Coste as Director and Audit Committee Chair
Zacks
19 days ago
5 Low-Leverage Stocks to Buy Amid Volatile Market Sentiment
Argus Research
25 days ago
BLFS: What does Argus have to say about BLFS?
Simply Wall St.
25 days ago
BioLife Solutions Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
GuruFocus.com
25 days ago
BioLife Solutions Inc (BLFS) Q4 2024 Earnings Call Highlights: Strong Margin Growth and ...
Thomson Reuters StreetEvents
25 days ago
Q4 2024 BioLife Solutions Inc Earnings Call
Compare BLFS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BLFS BioLife Solutions Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.